Microbot Medical to Host Call Addressing Misleading Third-Party Article with LIBERTY System Users
MBOT sits 20% above its 52-week low of $1.6.
Summary
Microbot Medical announced a conference call to refute a negative third-party article and provide accurate information on its LIBERTY robotic system, featuring testimonials from current users.
Key Events · Corporate Governance and Compliance · MBOT
-
Conference Call Announced
Microbot Medical will host an analysts and investors conference call on Monday, May 18th, 2026, at 3:00 PM ET.
-
Addressing Misinformation
The call will specifically address and correct "misleading statements and misrepresentations" made in a recent unaffiliated third-party article.
-
User Testimonials Featured
Key users of the LIBERTY System, Dr. Charles Briggs (Tampa General Hospital) and Dr. Zachary L. Bercu (Emory Healthcare), will join the call to share their experiences and refute inaccuracies attributed to them.
Analysis · MBOT · Industrial Applications And Services
Microbot Medical is proactively addressing a recent negative third-party article by hosting a conference call with analysts, investors, and key users of its LIBERTY Endovascular Robotic System. This move aims to correct "misleading statements and misrepresentations" and ensure accurate public information, which is crucial for investor confidence, especially given the company's recent commercial momentum and ongoing ATM offering. The market will be closely watching the call for details on the alleged misinformation and the company's rebuttal.
At the time of this filing, MBOT was trading at $1.92 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $128.6M. The 52-week trading range was $1.60 to $4.67. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.